✦ LIBER ✦
267 DERMATOLOGIC ADVERSE EVENTS WITHIN THE FIRST 60 DAYS OF SORAFENIB TREATMENT ARE ASSOCIATED WITH BETTER OVERALL SURVIVAL (OS) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
✍ Scribed by Reig, M.; Rodriguez de Lope, C.; Llarch, N.; Forner, A.; Torres, F.; Rios, J.; Boix, L.; Rimola, J.; Darnell, A.; Ayuso, C.; Bruix, J.
- Book ID
- 123373581
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 53 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.